Article
Activation of GRP/GRP-R signaling contributes to castration-resistant prostate cancer progression.
Oncotarget - 20 Sept 2016
Qiao Jingbo, Grabowska Magdalena M, Forestier-Roman Ingrid S, Mirosevich Janni, Case Thomas C, Chung Dai H, Cates Justin M M, Matusik Robert J, Manning H Charles, Jin Renjie
Abstract excerpt
Numerous studies indicate that androgen receptor splice variants (ARVs) play a critical role in the development of castration-resistant prostate cancer (CRPC), including the resistance to the new generation of inhibitors of androgen receptor (AR) action. Previously, we demonstrated that activation of NF-κB signaling increases ARVs expression in prostate cancer (PC) cells, thereby promoting progression to CRPC....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
